Skip to main content
BRNS logo

BRNS · Barinthus Biotherapeutics plc. · Proposed Sales

Track BRNS — free
$0.74 -0.02 (-2.49%) At close · Sep 8
Market Cap
$30.23M
Shares
40.85M

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

No Proposed Sales

No Form 144 proposed-sale notices are available for this stock yet.

Key facts CIK 1828185 CUSIP 91864C107 13F (30d) 6 filings 6 filers Visit website Investor relations